Advertisement

Topics

Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development

02:34 EDT 27 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development. Through this partnership, both companies will leverage their comprehensive knowle...

Other Sources for this Article

MEDIA:
Strategia Holdings, LLC
Mito Aoki Koya
General Manager
contact@strategiatx.com
Website: www.strategiatx.com

NEXT ARTICLE

More From BioPortfolio on "Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...